Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | %Female (2009) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Current Cancer Drug Targets | journal | 2.329 Q1 | 103 | 75 | 194 | 9712 | 1095 | 185 | 5.45 | 129.49 | 35.91 |  |
| 2 | Current Drug Targets | journal | 1.775 Q1 | 119 | 131 | 427 | 12582 | 1765 | 379 | 3.86 | 96.05 | 34.77 | |
| 3 | CNS and Neurological Disorders - Drug Targets | journal | 1.772 Q1 | 96 | 52 | 150 | 4787 | 614 | 134 | 3.85 | 92.06 | 40.00 | |
| 4 | Current Medicinal Chemistry | journal | 1.758 Q1 | 202 | 282 | 767 | 43990 | 4314 | 766 | 5.35 | 155.99 | 35.58 | |
| 5 | Current Pharmaceutical Design | journal | 1.605 Q1 | 183 | 349 | 1097 | 40829 | 4830 | 980 | 4.56 | 116.99 | 30.71 | |
| 6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.424 Q1 | 108 | 93 | 182 | 9648 | 833 | 167 | 4.33 | 103.74 | 30.12 | |
| 7 | Current Vascular Pharmacology | journal | 1.046 Q2 | 69 | 56 | 109 | 6582 | 355 | 102 | 3.15 | 117.54 | 24.84 | |
| 8 | Current Neuropharmacology | journal | 1.038 Q2 | 103 | 35 | 81 | 3841 | 197 | 79 | 2.09 | 109.74 | 30.38 | |
| 9 | Reviews on Recent Clinical Trials | journal | 0.987 Q2 | 35 | 26 | 85 | 1496 | 253 | 80 | 3.15 | 57.54 | 38.54 | |
| 10 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 Q2 | 107 | 149 | 394 | 14757 | 1314 | 391 | 3.26 | 99.04 | 33.26 | |
| 11 | Current Molecular Pharmacology | journal | 0.438 Q3 | 49 | 27 | 23 | 3594 | 29 | 23 | 1.26 | 133.11 | 34.67 | |
| 12 | Current Drug Safety | journal | 0.343 Q3 | 41 | 29 | 96 | 1359 | 175 | 93 | 1.81 | 46.86 | 35.58 | |
| 13 | Current Radiopharmaceuticals | journal | 32 | 33 | 0 | 1338 | 0 | 0 | 0.00 | 40.55 | 32.52 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data